Sign In
Buy CBLI
$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022
The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment
12:00am, Tuesday, 05'th Nov 2019The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch
11:06am, Wednesday, 16'th Oct 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 15) Celgene Corporation (NASDAQ: CELG ) Eagle Pharmace
The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
12:00am, Tuesday, 15'th Oct 2019Here's Why We're Watching Cleveland BioLabs's (NASDAQ:CBLI) Cash Burn Situation
02:25pm, Friday, 04'th Oct 2019
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Some Cleveland BioLabs (NASDAQ:CBLI) Shareholders Have Taken A Painful 83% Share Price Drop
05:40pm, Tuesday, 20'th Aug 2019
We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...
Cleveland BioLabs Reports Second Quarter 2019 Financial Results and Development Progress
12:30pm, Wednesday, 14'th Aug 2019
BUFFALO, NY / ACCESSWIRE / August 14, 2019 / Cleveland BioLabs, Inc. (NASDAQ:CBLI) today reported financial results and development progress for the second quarter ended June 30, 2019. Cleveland BioLa
